{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-025037","form_type":"8-K","ticker":"AKTX","cik":"0001541157","company_name":"Akari Therapeutics Plc","filed_at":"2026-05-22T20:30:23+00:00","discovered_at":"2026-05-22T20:32:00.483960+00:00","generated_at":"2026-05-22T20:52:27.140000+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"confidence":"high","headline":"Akari Therapeutics raises ~$5.5M via private placement of ADSs and warrants","bullets":["Gross proceeds of ~$5.5M from 1,470,588 ADSs at $3.74 per unit; three closings through July 15, 2026.","Each unit includes one ADS (or pre-funded warrant) plus Series H/I/J warrants exercisable at $3.74 per ADS.","Warrants require shareholder approval; pre-funded warrants exercisable immediately.","Net proceeds for working capital and general corporate purposes; Paulson Investment paid 2% cash fee plus 117,647 ADSs.","Offering exempt from registration under Section 4(a)(2) and Regulation D."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-025037","json":"https://secwatch.observer/filing/0001493152-26-025037.json","markdown":"https://secwatch.observer/filing/0001493152-26-025037.md","text":"https://secwatch.observer/filing/0001493152-26-025037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1541157/000149315226025037/0001493152-26-025037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1541157/000149315226025037/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T20:52:27.140000+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}